Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors is a research paper published in Molecular Therapy (2022). On theSindex it has a DataRank of 0.494. It has been cited 26 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.494
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: AI108197
National Institutes of Health
Grant: AI149644
National Institutes of Health
Grant: AI151797
National Institutes of Health
Grant: 01KI20198A
National Institutes of Health
Grant: TRR186
National Institutes of Health
Grant: 01KI20239B
National Institutes of Health
Grant: 278001972
National Institutes of Health
Grant: 33.7533.-6-21/5/1
National Institutes of Health
Grant: 415089553
National Institutes of Health
Grant: 416072091
Deutsches Zentrum fur Infektionsforschung eV
Grant: TTU-HIV 04.819
Deutsche Forschungsgemeinschaft
Grant: EXC81
NIAID NIH HHS
Grant: R01 AI108197
NIAID NIH HHS
Grant: U01 AI149644
NIAID NIH HHS
Grant: U01 AI151797
FWCI
4.05
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals